

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | surfactant homeostasis (GO:0043129) | 4.86414808 |
| 2 | hemidesmosome assembly (GO:0031581) | 4.72953788 |
| 3 | positive regulation of histone deacetylation (GO:0031065) | 4.18147270 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.04200491 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.04200491 |
| 6 | pre-miRNA processing (GO:0031054) | 3.96308492 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.92304112 |
| 8 | Golgi transport vesicle coating (GO:0048200) | 3.81091364 |
| 9 | COPI coating of Golgi vesicle (GO:0048205) | 3.81091364 |
| 10 | cell adhesion mediated by integrin (GO:0033627) | 3.72635859 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.68273350 |
| 12 | positive T cell selection (GO:0043368) | 3.67375120 |
| 13 | positive thymic T cell selection (GO:0045059) | 3.66969082 |
| 14 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.61657855 |
| 15 | chemical homeostasis within a tissue (GO:0048875) | 3.55265156 |
| 16 | negative T cell selection (GO:0043383) | 3.54003516 |
| 17 | peptidyl-lysine dimethylation (GO:0018027) | 3.50623155 |
| 18 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.44450595 |
| 19 | hypotonic response (GO:0006971) | 3.37935309 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.35479074 |
| 21 | T cell selection (GO:0045058) | 3.29586939 |
| 22 | negative thymic T cell selection (GO:0045060) | 3.28657707 |
| 23 | thymic T cell selection (GO:0045061) | 3.25721569 |
| 24 | skin morphogenesis (GO:0043589) | 3.20906825 |
| 25 | sodium ion export (GO:0071436) | 3.20319672 |
| 26 | regulation of early endosome to late endosome transport (GO:2000641) | 3.10643515 |
| 27 | negative regulation of histone methylation (GO:0031061) | 3.09891096 |
| 28 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.08987024 |
| 29 | cell-substrate junction assembly (GO:0007044) | 3.08544704 |
| 30 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.07402285 |
| 31 | locomotory exploration behavior (GO:0035641) | 3.02454919 |
| 32 | response to laminar fluid shear stress (GO:0034616) | 2.99492443 |
| 33 | layer formation in cerebral cortex (GO:0021819) | 2.98262341 |
| 34 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.95686621 |
| 35 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.93673480 |
| 36 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.92965264 |
| 37 | regulation of podosome assembly (GO:0071801) | 2.91083677 |
| 38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.86826070 |
| 39 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.86446089 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.86446089 |
| 41 | regulation of ARF GTPase activity (GO:0032312) | 2.84999247 |
| 42 | regulation of ARF protein signal transduction (GO:0032012) | 2.84952456 |
| 43 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.81176673 |
| 44 | synaptic vesicle maturation (GO:0016188) | 2.80830470 |
| 45 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.78429443 |
| 46 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.78202947 |
| 47 | signal complex assembly (GO:0007172) | 2.78179032 |
| 48 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.74316747 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.74005442 |
| 50 | histone H3-K9 demethylation (GO:0033169) | 2.73188143 |
| 51 | barbed-end actin filament capping (GO:0051016) | 2.72376289 |
| 52 | positive regulation of Rap GTPase activity (GO:0032854) | 2.71985127 |
| 53 | response to interleukin-15 (GO:0070672) | 2.70224221 |
| 54 | positive regulation of protein deacetylation (GO:0090312) | 2.69697106 |
| 55 | negative regulation of interleukin-12 production (GO:0032695) | 2.69602869 |
| 56 | negative regulation of anoikis (GO:2000811) | 2.68712708 |
| 57 | protein localization to endosome (GO:0036010) | 2.68670592 |
| 58 | cortical actin cytoskeleton organization (GO:0030866) | 2.65941119 |
| 59 | natural killer cell differentiation (GO:0001779) | 2.64858211 |
| 60 | stress granule assembly (GO:0034063) | 2.64258458 |
| 61 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64256357 |
| 62 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64256357 |
| 63 | modulation by symbiont of host immune response (GO:0052553) | 2.64256357 |
| 64 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64256357 |
| 65 | modulation by symbiont of host defense response (GO:0052031) | 2.64256357 |
| 66 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64256357 |
| 67 | endodermal cell differentiation (GO:0035987) | 2.63951439 |
| 68 | regulation of chromatin binding (GO:0035561) | 2.62985915 |
| 69 | response to muramyl dipeptide (GO:0032495) | 2.62944238 |
| 70 | response to peptidoglycan (GO:0032494) | 2.62280070 |
| 71 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61824868 |
| 72 | regulation of defense response to virus by virus (GO:0050690) | 2.59474871 |
| 73 | modulation by symbiont of host cellular process (GO:0044068) | 2.57656765 |
| 74 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.57182799 |
| 75 | positive regulation of tolerance induction (GO:0002645) | 2.56168192 |
| 76 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.55381348 |
| 77 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.55331909 |
| 78 | regulation of T cell tolerance induction (GO:0002664) | 2.53236922 |
| 79 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.52722770 |
| 80 | establishment of nucleus localization (GO:0040023) | 2.52617823 |
| 81 | substrate-dependent cell migration (GO:0006929) | 2.51269038 |
| 82 | regulation of Rap GTPase activity (GO:0032317) | 2.50766106 |
| 83 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.50086373 |
| 84 | regulation of anoikis (GO:2000209) | 2.48990889 |
| 85 | macrophage activation involved in immune response (GO:0002281) | 2.48208870 |
| 86 | iron ion import (GO:0097286) | 2.48083743 |
| 87 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.47731315 |
| 88 | positive regulation of nuclease activity (GO:0032075) | 2.47662710 |
| 89 | T cell costimulation (GO:0031295) | 2.47133972 |
| 90 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.46138936 |
| 91 | regulation of RNA export from nucleus (GO:0046831) | 2.45537550 |
| 92 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.45422511 |
| 93 | cellular potassium ion homeostasis (GO:0030007) | 2.45305299 |
| 94 | positive regulation of RNA splicing (GO:0033120) | 2.44989008 |
| 95 | regulation of vitamin metabolic process (GO:0030656) | 2.43880737 |
| 96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.42650616 |
| 97 | negative regulation of cell size (GO:0045792) | 2.42541413 |
| 98 | semaphorin-plexin signaling pathway (GO:0071526) | 2.42210831 |
| 99 | mesodermal cell differentiation (GO:0048333) | 2.41528323 |
| 100 | lymphocyte costimulation (GO:0031294) | 2.40915671 |
| 101 | vesicle coating (GO:0006901) | 2.39824532 |
| 102 | histone H3-K36 demethylation (GO:0070544) | 2.39813345 |
| 103 | endothelial cell chemotaxis (GO:0035767) | 2.39483194 |
| 104 | regulation of translational fidelity (GO:0006450) | 2.37866666 |
| 105 | NLS-bearing protein import into nucleus (GO:0006607) | 2.37672135 |
| 106 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.37606824 |
| 107 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.37354702 |
| 108 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.37290245 |
| 109 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.35928652 |
| 110 | activated T cell proliferation (GO:0050798) | 2.35871031 |
| 111 | detection of molecule of bacterial origin (GO:0032490) | 2.35725108 |
| 112 | epithelial cell-cell adhesion (GO:0090136) | 2.35671601 |
| 113 | T cell receptor signaling pathway (GO:0050852) | 2.35592046 |
| 114 | regulation of histone deacetylation (GO:0031063) | 2.34908235 |
| 115 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.34494399 |
| 116 | embryonic process involved in female pregnancy (GO:0060136) | 2.34462763 |
| 117 | glial cell proliferation (GO:0014009) | 2.33937498 |
| 118 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.33866598 |
| 119 | stress fiber assembly (GO:0043149) | 2.33170571 |
| 120 | NIK/NF-kappaB signaling (GO:0038061) | 2.32966115 |
| 121 | germinal center formation (GO:0002467) | 2.32667238 |
| 122 | apoptotic cell clearance (GO:0043277) | 2.32279775 |
| 123 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.31954137 |
| 124 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.31577908 |
| 125 | response to vitamin D (GO:0033280) | 2.31185596 |
| 126 | adherens junction assembly (GO:0034333) | 2.30676602 |
| 127 | positive regulation of receptor recycling (GO:0001921) | 2.30612026 |
| 128 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.30403367 |
| 129 | clathrin coat assembly (GO:0048268) | 2.30049558 |
| 130 | peptidyl-threonine modification (GO:0018210) | 2.26702655 |
| 131 | membrane protein ectodomain proteolysis (GO:0006509) | 2.26653890 |
| 132 | dorsal/ventral axis specification (GO:0009950) | 2.25897049 |
| 133 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.25845496 |
| 134 | nerve growth factor signaling pathway (GO:0038180) | 2.25649736 |
| 135 | cellular response to vitamin D (GO:0071305) | 2.24923802 |
| 136 | negative regulation of fatty acid transport (GO:2000192) | 2.24593629 |
| 137 | T-helper 1 type immune response (GO:0042088) | 2.23947623 |
| 138 | activation of protein kinase A activity (GO:0034199) | 2.23310190 |
| 139 | regulation of nuclease activity (GO:0032069) | 2.22603224 |
| 140 | histone H4-K16 acetylation (GO:0043984) | 2.21847289 |
| 141 | detection of other organism (GO:0098543) | 2.21375468 |
| 142 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.21023807 |
| 143 | B cell receptor signaling pathway (GO:0050853) | 2.20401752 |
| 144 | nuclear pore complex assembly (GO:0051292) | 2.19430095 |
| 145 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.19246124 |
| 146 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.19210142 |
| 147 | negative regulation of GTP catabolic process (GO:0033125) | 2.18688338 |
| 148 | negative regulation of GTPase activity (GO:0034260) | 2.18688338 |
| 149 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.18341487 |
| 150 | activation of Rac GTPase activity (GO:0032863) | 2.18039191 |
| 151 | peptidyl-threonine phosphorylation (GO:0018107) | 2.17844715 |
| 152 | membrane raft organization (GO:0031579) | 2.16954334 |
| 153 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.16407841 |
| 154 | activation of JUN kinase activity (GO:0007257) | 2.15313480 |
| 155 | cortical cytoskeleton organization (GO:0030865) | 2.14635545 |
| 156 | focal adhesion assembly (GO:0048041) | 2.14248277 |
| 157 | cell-substrate adherens junction assembly (GO:0007045) | 2.14248277 |
| 158 | cellular response to virus (GO:0098586) | 2.14137184 |
| 159 | histone H3-K4 methylation (GO:0051568) | 2.13138996 |
| 160 | regulation of growth hormone secretion (GO:0060123) | 2.13092082 |
| 161 | histone lysine demethylation (GO:0070076) | 2.12538427 |
| 162 | receptor catabolic process (GO:0032801) | 2.12205239 |
| 163 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.11891496 |
| 164 | corticosteroid receptor signaling pathway (GO:0031958) | 2.11505106 |
| 165 | positive regulation of p38MAPK cascade (GO:1900745) | 2.11363009 |
| 166 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.11014144 |
| 167 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.10880955 |
| 168 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.10850619 |
| 169 | endocytic recycling (GO:0032456) | 2.10734848 |
| 170 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.10565815 |
| 171 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.10354822 |
| 172 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.10286695 |
| 173 | histone H2A monoubiquitination (GO:0035518) | 2.10164300 |
| 174 | negative regulation of type 2 immune response (GO:0002829) | 2.09746824 |
| 175 | regulation of tolerance induction (GO:0002643) | 2.09370986 |
| 176 | polarized epithelial cell differentiation (GO:0030859) | 2.09237408 |
| 177 | positive regulation of astrocyte differentiation (GO:0048711) | 2.09044531 |
| 178 | regulation of protein deacetylation (GO:0090311) | 2.09038557 |
| 179 | basement membrane organization (GO:0071711) | 2.08533823 |
| 180 | detection of external biotic stimulus (GO:0098581) | 2.08509427 |
| 181 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.06765806 |
| 182 | activation of MAPKKK activity (GO:0000185) | 2.05857753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.78333860 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.18124113 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 4.13592126 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.40549072 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.32992807 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.02791882 |
| 7 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.96250628 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.82197420 |
| 9 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.79855173 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.68756521 |
| 11 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.52602170 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.50644234 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.42725598 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.41931505 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41006134 |
| 16 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.38251607 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.35437611 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31076162 |
| 19 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.30793596 |
| 20 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.27103048 |
| 21 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.26121439 |
| 22 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.23476290 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.23249914 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.20457662 |
| 25 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 2.16807009 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 2.12099278 |
| 27 | KDM2B_26808549_Chip-Seq_K562_Human | 2.11397579 |
| 28 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.10672685 |
| 29 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.08331221 |
| 30 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 2.08329335 |
| 31 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.08253999 |
| 32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.03328892 |
| 33 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.00582069 |
| 34 | MAF_26560356_Chip-Seq_TH1_Human | 1.97878150 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.95048161 |
| 36 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91817460 |
| 37 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88738457 |
| 38 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87593162 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.82307812 |
| 40 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.77187159 |
| 41 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.75797013 |
| 42 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.75797013 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.70667802 |
| 44 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.67246437 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66252979 |
| 46 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65744010 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.65072477 |
| 48 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63797865 |
| 49 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.63649281 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63335723 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62953961 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.62259044 |
| 53 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.62139169 |
| 54 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.61946699 |
| 55 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.61690812 |
| 56 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.60412169 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59710763 |
| 58 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.59001143 |
| 59 | MYB_26560356_Chip-Seq_TH2_Human | 1.58566207 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.55034015 |
| 61 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.50825893 |
| 62 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.50712546 |
| 63 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50504167 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49292727 |
| 65 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.48127375 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47419428 |
| 67 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.43170783 |
| 68 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.43142803 |
| 69 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.43054772 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42217344 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.39402166 |
| 72 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39027596 |
| 73 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.39006530 |
| 74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38079641 |
| 75 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36863634 |
| 76 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.36715307 |
| 77 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35351216 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.34311100 |
| 79 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.34062216 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30722527 |
| 81 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.30262610 |
| 82 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.29516571 |
| 83 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29274381 |
| 84 | MYB_26560356_Chip-Seq_TH1_Human | 1.28914999 |
| 85 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27331677 |
| 86 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.26848006 |
| 87 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25155461 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.24841682 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.24834077 |
| 90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23702851 |
| 91 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.23519073 |
| 92 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.23367048 |
| 93 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.22974506 |
| 94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22063537 |
| 95 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21026434 |
| 96 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18946505 |
| 97 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18161854 |
| 98 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.17926124 |
| 99 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.17664987 |
| 100 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17215920 |
| 101 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.16257414 |
| 102 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.15763457 |
| 103 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.15149659 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.13700273 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08358757 |
| 106 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08188942 |
| 107 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08188942 |
| 108 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.07582655 |
| 109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07581422 |
| 110 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.07176319 |
| 111 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06965369 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05839027 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04581896 |
| 114 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.03691579 |
| 115 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02801101 |
| 116 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.02387411 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.01928811 |
| 118 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00777984 |
| 119 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99445882 |
| 120 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99406458 |
| 121 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99329863 |
| 122 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.98747387 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98392516 |
| 124 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.98055502 |
| 125 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.96805977 |
| 126 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.96690700 |
| 127 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96303555 |
| 128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92525167 |
| 129 | GATA1_22025678_ChIP-Seq_K562_Human | 0.92060549 |
| 130 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.90679650 |
| 131 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90173970 |
| 132 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.89821554 |
| 133 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89259758 |
| 134 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.88981371 |
| 135 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.88381019 |
| 136 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88241596 |
| 137 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88039739 |
| 138 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86516088 |
| 139 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85811387 |
| 140 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.85534873 |
| 141 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.84007565 |
| 142 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83913821 |
| 143 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83340523 |
| 144 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.82971404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003300_gastrointestinal_ulcer | 3.27971802 |
| 2 | MP0005076_abnormal_cell_differentiation | 2.90526050 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 2.90109243 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 2.75496497 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 2.65987067 |
| 6 | MP0003453_abnormal_keratinocyte_physiol | 2.61146428 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.57008158 |
| 8 | MP0008961_abnormal_basal_metabolism | 2.55209174 |
| 9 | MP0002909_abnormal_adrenal_gland | 2.55112301 |
| 10 | MP0003436_decreased_susceptibility_to | 2.34479037 |
| 11 | MP0010352_gastrointestinal_tract_polyps | 2.25048878 |
| 12 | MP0003303_peritoneal_inflammation | 2.23090582 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.22591635 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.21892407 |
| 15 | MP0000685_abnormal_immune_system | 1.96446869 |
| 16 | MP0005257_abnormal_intraocular_pressure | 1.95762112 |
| 17 | MP0005023_abnormal_wound_healing | 1.93192729 |
| 18 | MP0000569_abnormal_digit_pigmentation | 1.90224283 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.86408551 |
| 20 | MP0000537_abnormal_urethra_morphology | 1.86368007 |
| 21 | MP0001849_ear_inflammation | 1.82326664 |
| 22 | MP0000579_abnormal_nail_morphology | 1.82325599 |
| 23 | MP0000858_altered_metastatic_potential | 1.82253948 |
| 24 | MP0004782_abnormal_surfactant_physiolog | 1.78590106 |
| 25 | MP0005409_darkened_coat_color | 1.78493343 |
| 26 | MP0003045_fibrosis | 1.75811471 |
| 27 | MP0004272_abnormal_basement_membrane | 1.74865685 |
| 28 | MP0002653_abnormal_ependyma_morphology | 1.74705940 |
| 29 | MP0003448_altered_tumor_morphology | 1.74581098 |
| 30 | MP0003122_maternal_imprinting | 1.72814495 |
| 31 | MP0003283_abnormal_digestive_organ | 1.71503548 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.67165310 |
| 33 | MP0000703_abnormal_thymus_morphology | 1.65303860 |
| 34 | MP0006054_spinal_hemorrhage | 1.63920166 |
| 35 | MP0003724_increased_susceptibility_to | 1.62653938 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.61015045 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.59397839 |
| 38 | MP0005451_abnormal_body_composition | 1.56526428 |
| 39 | MP0009278_abnormal_bone_marrow | 1.55287862 |
| 40 | MP0008260_abnormal_autophagy | 1.54362002 |
| 41 | MP0002060_abnormal_skin_morphology | 1.53384560 |
| 42 | MP0003828_pulmonary_edema | 1.53383534 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.51931730 |
| 44 | MP0003172_abnormal_lysosome_physiology | 1.50913745 |
| 45 | MP0002998_abnormal_bone_remodeling | 1.49265626 |
| 46 | MP0005275_abnormal_skin_tensile | 1.48488610 |
| 47 | MP0003787_abnormal_imprinting | 1.48441921 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.46456493 |
| 49 | MP0002419_abnormal_innate_immunity | 1.43650633 |
| 50 | MP0006072_abnormal_retinal_apoptosis | 1.39695547 |
| 51 | MP0006082_CNS_inflammation | 1.39158410 |
| 52 | MP0000003_abnormal_adipose_tissue | 1.38438828 |
| 53 | MP0002398_abnormal_bone_marrow | 1.36934348 |
| 54 | MP0003123_paternal_imprinting | 1.36843636 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.35416819 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.34062451 |
| 57 | MP0004947_skin_inflammation | 1.33575122 |
| 58 | MP0008004_abnormal_stomach_pH | 1.33076867 |
| 59 | MP0003091_abnormal_cell_migration | 1.32433932 |
| 60 | MP0009785_altered_susceptibility_to | 1.31893031 |
| 61 | MP0004885_abnormal_endolymph | 1.31358187 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.29623770 |
| 63 | MP0003075_altered_response_to | 1.29126183 |
| 64 | MP0004858_abnormal_nervous_system | 1.29021705 |
| 65 | MP0003121_genomic_imprinting | 1.28769188 |
| 66 | MP0001216_abnormal_epidermal_layer | 1.27964608 |
| 67 | MP0001851_eye_inflammation | 1.27713290 |
| 68 | MP0003635_abnormal_synaptic_transmissio | 1.26517344 |
| 69 | MP0005000_abnormal_immune_tolerance | 1.25061766 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.24737202 |
| 71 | MP0001835_abnormal_antigen_presentation | 1.22944183 |
| 72 | MP0000733_abnormal_muscle_development | 1.22459253 |
| 73 | MP0009840_abnormal_foam_cell | 1.20974665 |
| 74 | MP0005025_abnormal_response_to | 1.20730402 |
| 75 | MP0000428_abnormal_craniofacial_morphol | 1.19884574 |
| 76 | MP0002796_impaired_skin_barrier | 1.19660046 |
| 77 | MP0001790_abnormal_immune_system | 1.18998592 |
| 78 | MP0005387_immune_system_phenotype | 1.18998592 |
| 79 | MP0000604_amyloidosis | 1.18587297 |
| 80 | MP0010155_abnormal_intestine_physiology | 1.16689784 |
| 81 | MP0003279_aneurysm | 1.15659390 |
| 82 | MP0001800_abnormal_humoral_immune | 1.15377249 |
| 83 | MP0004233_abnormal_muscle_weight | 1.15040738 |
| 84 | MP0004510_myositis | 1.13847042 |
| 85 | MP0002084_abnormal_developmental_patter | 1.09733360 |
| 86 | MP0008770_decreased_survivor_rate | 1.09207979 |
| 87 | MP0005164_abnormal_response_to | 1.08587710 |
| 88 | MP0001299_abnormal_eye_distance/ | 1.05930623 |
| 89 | MP0005187_abnormal_penis_morphology | 1.04800159 |
| 90 | MP0002089_abnormal_postnatal_growth/wei | 1.04798291 |
| 91 | MP0003941_abnormal_skin_development | 1.04713540 |
| 92 | MP0001958_emphysema | 1.04015729 |
| 93 | MP0001853_heart_inflammation | 1.03833696 |
| 94 | MP0002234_abnormal_pharynx_morphology | 1.03659593 |
| 95 | MP0003890_abnormal_embryonic-extraembry | 1.02679546 |
| 96 | MP0009053_abnormal_anal_canal | 1.01286623 |
| 97 | MP0002722_abnormal_immune_system | 1.01197955 |
| 98 | MP0005375_adipose_tissue_phenotype | 1.00763412 |
| 99 | MP0004197_abnormal_fetal_growth/weight/ | 1.00759714 |
| 100 | MP0010678_abnormal_skin_adnexa | 1.00507039 |
| 101 | MP0001944_abnormal_pancreas_morphology | 0.99851671 |
| 102 | MP0002006_tumorigenesis | 0.99471763 |
| 103 | MP0003566_abnormal_cell_adhesion | 0.98699468 |
| 104 | MP0004811_abnormal_neuron_physiology | 0.98480661 |
| 105 | MP0000762_abnormal_tongue_morphology | 0.98358567 |
| 106 | MP0005388_respiratory_system_phenotype | 0.98156784 |
| 107 | MP0002133_abnormal_respiratory_system | 0.98156784 |
| 108 | MP0001348_abnormal_lacrimal_gland | 0.97797642 |
| 109 | MP0000343_altered_response_to | 0.97490267 |
| 110 | MP0008569_lethality_at_weaning | 0.96858612 |
| 111 | MP0003866_abnormal_defecation | 0.95379736 |
| 112 | MP0000716_abnormal_immune_system | 0.93346862 |
| 113 | MP0002925_abnormal_cardiovascular_devel | 0.93319841 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.92787619 |
| 115 | MP0003329_amyloid_beta_deposits | 0.92786816 |
| 116 | MP0005671_abnormal_response_to | 0.91179738 |
| 117 | MP0005621_abnormal_cell_physiology | 0.90438827 |
| 118 | MP0001915_intracranial_hemorrhage | 0.90382831 |
| 119 | MP0002420_abnormal_adaptive_immunity | 0.90131405 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.90048911 |
| 121 | MP0002723_abnormal_immune_serum | 0.89748193 |
| 122 | MP0002697_abnormal_eye_size | 0.89371391 |
| 123 | MP0000689_abnormal_spleen_morphology | 0.89227387 |
| 124 | MP0003119_abnormal_digestive_system | 0.88741470 |
| 125 | MP0004270_analgesia | 0.88280819 |
| 126 | MP0002092_abnormal_eye_morphology | 0.86737508 |
| 127 | MP0000490_abnormal_crypts_of | 0.86187631 |
| 128 | MP0001819_abnormal_immune_cell | 0.86151354 |
| 129 | MP0001879_abnormal_lymphatic_vessel | 0.85446047 |
| 130 | MP0003690_abnormal_glial_cell | 0.85053594 |
| 131 | MP0005390_skeleton_phenotype | 0.84285419 |
| 132 | MP0001542_abnormal_bone_strength | 0.84218631 |
| 133 | MP0005501_abnormal_skin_physiology | 0.84051870 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.83157259 |
| 135 | MP0010368_abnormal_lymphatic_system | 0.83115960 |
| 136 | MP0002086_abnormal_extraembryonic_tissu | 0.82842929 |
| 137 | MP0005166_decreased_susceptibility_to | 0.82630876 |
| 138 | MP0003634_abnormal_glial_cell | 0.82388979 |
| 139 | MP0009703_decreased_birth_body | 0.82108934 |
| 140 | MP0003861_abnormal_nervous_system | 0.81968382 |
| 141 | MP0005165_increased_susceptibility_to | 0.81857065 |
| 142 | MP0002933_joint_inflammation | 0.80574538 |
| 143 | MP0003115_abnormal_respiratory_system | 0.80451425 |
| 144 | MP0010307_abnormal_tumor_latency | 0.79754630 |
| 145 | MP0000350_abnormal_cell_proliferation | 0.79602651 |
| 146 | MP0002168_other_aberrant_phenotype | 0.78903761 |
| 147 | MP0003656_abnormal_erythrocyte_physiolo | 0.78730301 |
| 148 | MP0009333_abnormal_splenocyte_physiolog | 0.78529967 |
| 149 | MP0001730_embryonic_growth_arrest | 0.78389526 |
| 150 | MP0002429_abnormal_blood_cell | 0.78204493 |
| 151 | MP0005197_abnormal_uvea_morphology | 0.76952536 |
| 152 | MP0002085_abnormal_embryonic_tissue | 0.76842601 |
| 153 | MP0001545_abnormal_hematopoietic_system | 0.76352094 |
| 154 | MP0005397_hematopoietic_system_phenotyp | 0.76352094 |
| 155 | MP0002452_abnormal_antigen_presenting | 0.74742069 |
| 156 | MP0001845_abnormal_inflammatory_respons | 0.74287943 |
| 157 | MP0002152_abnormal_brain_morphology | 0.72843557 |
| 158 | MP0000778_abnormal_nervous_system | 0.72800284 |
| 159 | MP0001784_abnormal_fluid_regulation | 0.72083005 |
| 160 | MP0000955_abnormal_spinal_cord | 0.72070986 |
| 161 | MP0002405_respiratory_system_inflammati | 0.71068388 |
| 162 | MP0005499_abnormal_olfactory_system | 0.70735797 |
| 163 | MP0005394_taste/olfaction_phenotype | 0.70735797 |
| 164 | MP0002063_abnormal_learning/memory/cond | 0.70419507 |
| 165 | MP0001697_abnormal_embryo_size | 0.70394495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Atrophic scars (HP:0001075) | 3.63968955 |
| 2 | Macroorchidism (HP:0000053) | 3.57378976 |
| 3 | Premature rupture of membranes (HP:0001788) | 3.50985590 |
| 4 | Hyperacusis (HP:0010780) | 3.33459395 |
| 5 | Neurofibrillary tangles (HP:0002185) | 3.32830568 |
| 6 | Cerebral aneurysm (HP:0004944) | 3.30004457 |
| 7 | Milia (HP:0001056) | 3.09805977 |
| 8 | Insomnia (HP:0100785) | 2.94087730 |
| 9 | Eczematoid dermatitis (HP:0000976) | 2.75280598 |
| 10 | Abnormality of glycolipid metabolism (HP:0010969) | 2.72873878 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.72873878 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.72873878 |
| 13 | T lymphocytopenia (HP:0005403) | 2.69926887 |
| 14 | Aortic aneurysm (HP:0004942) | 2.67905956 |
| 15 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.64172346 |
| 16 | Thick nail (HP:0001805) | 2.60746916 |
| 17 | Osteolytic defects of the hand bones (HP:0009699) | 2.59437818 |
| 18 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.59437818 |
| 19 | Fragile skin (HP:0001030) | 2.59413564 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.53747036 |
| 21 | Vertebral arch anomaly (HP:0008438) | 2.52539513 |
| 22 | Neoplasm of the heart (HP:0100544) | 2.50502955 |
| 23 | Abnormality of the fingertips (HP:0001211) | 2.50179110 |
| 24 | Abnormality of T cell number (HP:0011839) | 2.43739626 |
| 25 | Resting tremor (HP:0002322) | 2.41711635 |
| 26 | Heterotopia (HP:0002282) | 2.40279486 |
| 27 | Abnormality of oral frenula (HP:0000190) | 2.37948900 |
| 28 | Elfin facies (HP:0004428) | 2.33590555 |
| 29 | Shallow orbits (HP:0000586) | 2.30270399 |
| 30 | Mitral valve prolapse (HP:0001634) | 2.28960564 |
| 31 | Fragile nails (HP:0001808) | 2.28756780 |
| 32 | Dilatation of the ascending aorta (HP:0005111) | 2.27098356 |
| 33 | Striae distensae (HP:0001065) | 2.26746358 |
| 34 | Pointed chin (HP:0000307) | 2.21816102 |
| 35 | Ankyloglossia (HP:0010296) | 2.20491559 |
| 36 | Abnormality of macrophages (HP:0004311) | 2.20447827 |
| 37 | Subacute progressive viral hepatitis (HP:0006572) | 2.19738073 |
| 38 | Renal duplication (HP:0000075) | 2.18219680 |
| 39 | Onycholysis (HP:0001806) | 2.17959713 |
| 40 | Recurrent bronchitis (HP:0002837) | 2.16935795 |
| 41 | Broad face (HP:0000283) | 2.12432754 |
| 42 | Bowel diverticulosis (HP:0005222) | 2.10669887 |
| 43 | Nuclear cataract (HP:0100018) | 2.10470605 |
| 44 | Gingivitis (HP:0000230) | 2.09405342 |
| 45 | Deep palmar crease (HP:0006191) | 2.09043094 |
| 46 | Papilloma (HP:0012740) | 2.08776691 |
| 47 | Verrucae (HP:0200043) | 2.08776691 |
| 48 | Short nail (HP:0001799) | 2.08574262 |
| 49 | Arterial tortuosity (HP:0005116) | 2.07730784 |
| 50 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.07701108 |
| 51 | Short 4th metacarpal (HP:0010044) | 2.07701108 |
| 52 | Recurrent bacterial skin infections (HP:0005406) | 2.06767183 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.04674356 |
| 54 | Overriding aorta (HP:0002623) | 2.03323713 |
| 55 | Recurrent abscess formation (HP:0002722) | 2.01194556 |
| 56 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.01102009 |
| 57 | Loss of speech (HP:0002371) | 2.01077080 |
| 58 | Aneurysm (HP:0002617) | 2.00294883 |
| 59 | Cervical subluxation (HP:0003308) | 1.98164468 |
| 60 | Obsessive-compulsive behavior (HP:0000722) | 1.97915815 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 1.97476486 |
| 62 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.97304060 |
| 63 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.97119268 |
| 64 | Peritonitis (HP:0002586) | 1.96605733 |
| 65 | Spinal cord lesions (HP:0100561) | 1.95547427 |
| 66 | Syringomyelia (HP:0003396) | 1.95547427 |
| 67 | Hand muscle atrophy (HP:0009130) | 1.94532566 |
| 68 | Renovascular hypertension (HP:0100817) | 1.93727037 |
| 69 | Increased density of long bones (HP:0006392) | 1.93391163 |
| 70 | Abnormality of nail color (HP:0100643) | 1.92720672 |
| 71 | Wormian bones (HP:0002645) | 1.92354770 |
| 72 | Astrocytoma (HP:0009592) | 1.89195821 |
| 73 | Abnormality of the astrocytes (HP:0100707) | 1.89195821 |
| 74 | Ridged nail (HP:0001807) | 1.88900967 |
| 75 | Upper limb amyotrophy (HP:0009129) | 1.88657365 |
| 76 | Distal upper limb amyotrophy (HP:0007149) | 1.88657365 |
| 77 | Natal tooth (HP:0000695) | 1.88537642 |
| 78 | Abnormality of the nasal mucosa (HP:0000433) | 1.88063179 |
| 79 | Nail dystrophy (HP:0008404) | 1.87456599 |
| 80 | Recurrent viral infections (HP:0004429) | 1.87076811 |
| 81 | Spondylolisthesis (HP:0003302) | 1.86690350 |
| 82 | Flat acetabular roof (HP:0003180) | 1.85989346 |
| 83 | Enlarged penis (HP:0000040) | 1.85520517 |
| 84 | Vascular tortuosity (HP:0004948) | 1.84218941 |
| 85 | Cellulitis (HP:0100658) | 1.83876322 |
| 86 | Blue sclerae (HP:0000592) | 1.78895359 |
| 87 | Interstitial pulmonary disease (HP:0006530) | 1.76495485 |
| 88 | Thin bony cortex (HP:0002753) | 1.76371508 |
| 89 | Trigonocephaly (HP:0000243) | 1.76323279 |
| 90 | Genu recurvatum (HP:0002816) | 1.76316377 |
| 91 | Obstructive sleep apnea (HP:0002870) | 1.76181424 |
| 92 | Cerebral inclusion bodies (HP:0100314) | 1.75648408 |
| 93 | Persistence of primary teeth (HP:0006335) | 1.75371731 |
| 94 | Dysostosis multiplex (HP:0000943) | 1.74822409 |
| 95 | Plantar hyperkeratosis (HP:0007556) | 1.74102386 |
| 96 | Hypercortisolism (HP:0001578) | 1.74059265 |
| 97 | Abnormality of the lower motor neuron (HP:0002366) | 1.73998379 |
| 98 | Narrow palate (HP:0000189) | 1.73592806 |
| 99 | Buphthalmos (HP:0000557) | 1.73534306 |
| 100 | Broad palm (HP:0001169) | 1.73215376 |
| 101 | Hematochezia (HP:0002573) | 1.73079773 |
| 102 | Long toe (HP:0010511) | 1.72834566 |
| 103 | Ependymoma (HP:0002888) | 1.72800385 |
| 104 | Selective tooth agenesis (HP:0001592) | 1.72379339 |
| 105 | Abnormal blistering of the skin (HP:0008066) | 1.72368201 |
| 106 | Basal cell carcinoma (HP:0002671) | 1.72215277 |
| 107 | Posterior subcapsular cataract (HP:0007787) | 1.71712535 |
| 108 | Hyperparathyroidism (HP:0000843) | 1.71341456 |
| 109 | Aqueductal stenosis (HP:0002410) | 1.71077083 |
| 110 | Volvulus (HP:0002580) | 1.70269406 |
| 111 | Bladder diverticulum (HP:0000015) | 1.70251587 |
| 112 | Depression (HP:0000716) | 1.69827148 |
| 113 | Ulnar bowing (HP:0003031) | 1.69656874 |
| 114 | Upper motor neuron abnormality (HP:0002127) | 1.68354002 |
| 115 | Spontaneous hematomas (HP:0007420) | 1.68278424 |
| 116 | Insidious onset (HP:0003587) | 1.67996849 |
| 117 | Termporal pattern (HP:0011008) | 1.67996849 |
| 118 | Orchitis (HP:0100796) | 1.67783314 |
| 119 | Increased nuchal translucency (HP:0010880) | 1.67701806 |
| 120 | Achilles tendon contracture (HP:0001771) | 1.67671076 |
| 121 | Supranuclear gaze palsy (HP:0000605) | 1.67518934 |
| 122 | Bicuspid aortic valve (HP:0001647) | 1.67127596 |
| 123 | Cupped ribs (HP:0000887) | 1.66192602 |
| 124 | Disproportionate tall stature (HP:0001519) | 1.64851435 |
| 125 | Apathy (HP:0000741) | 1.63736317 |
| 126 | Thyroiditis (HP:0100646) | 1.63297993 |
| 127 | Nasal polyposis (HP:0100582) | 1.63292826 |
| 128 | Absent frontal sinuses (HP:0002688) | 1.63166591 |
| 129 | Hypoventilation (HP:0002791) | 1.62014786 |
| 130 | Papilledema (HP:0001085) | 1.61729769 |
| 131 | Amyotrophic lateral sclerosis (HP:0007354) | 1.61575082 |
| 132 | Pelvic girdle muscle weakness (HP:0003749) | 1.61262798 |
| 133 | Emphysema (HP:0002097) | 1.61253254 |
| 134 | Sacral dimple (HP:0000960) | 1.60271542 |
| 135 | Abnormal ossification of hand bones (HP:0005921) | 1.59862731 |
| 136 | Long palpebral fissure (HP:0000637) | 1.58908924 |
| 137 | Postural tremor (HP:0002174) | 1.58291737 |
| 138 | Protrusio acetabuli (HP:0003179) | 1.57930754 |
| 139 | Truncal ataxia (HP:0002078) | 1.57801030 |
| 140 | Truncal obesity (HP:0001956) | 1.57671143 |
| 141 | Arnold-Chiari malformation (HP:0002308) | 1.57179510 |
| 142 | Asymmetry of the thorax (HP:0001555) | 1.56444544 |
| 143 | Periodontitis (HP:0000704) | 1.56419654 |
| 144 | Ankle contracture (HP:0006466) | 1.56371924 |
| 145 | Myositis (HP:0100614) | 1.55384377 |
| 146 | Aortic dissection (HP:0002647) | 1.55286918 |
| 147 | Viral hepatitis (HP:0006562) | 1.55046497 |
| 148 | Neuronal loss in central nervous system (HP:0002529) | 1.54771362 |
| 149 | Impaired smooth pursuit (HP:0007772) | 1.54440225 |
| 150 | Combined immunodeficiency (HP:0005387) | 1.54387148 |
| 151 | Aplasia cutis congenita (HP:0001057) | 1.53748796 |
| 152 | Amyloidosis (HP:0011034) | 1.53719890 |
| 153 | Severe combined immunodeficiency (HP:0004430) | 1.53657892 |
| 154 | Increased connective tissue (HP:0009025) | 1.53639714 |
| 155 | Disinhibition (HP:0000734) | 1.53620837 |
| 156 | Broad thumb (HP:0011304) | 1.53061640 |
| 157 | Diminished motivation (HP:0000745) | 1.53007023 |
| 158 | Bone pain (HP:0002653) | 1.52860664 |
| 159 | Frequent falls (HP:0002359) | 1.52475973 |
| 160 | Colitis (HP:0002583) | 1.52464440 |
| 161 | Visual hallucinations (HP:0002367) | 1.52438339 |
| 162 | Broad metatarsal (HP:0001783) | 1.52010282 |
| 163 | Fibrous tissue neoplasm (HP:0012316) | 1.51302618 |
| 164 | Hypoplasia of the thymus (HP:0000778) | 1.51263122 |
| 165 | Abnormality of dentin (HP:0010299) | 1.51130874 |
| 166 | Mediastinal lymphadenopathy (HP:0100721) | 1.50933106 |
| 167 | Aseptic necrosis (HP:0010885) | 1.50588473 |
| 168 | Abnormality of the 4th metacarpal (HP:0010012) | 1.50396470 |
| 169 | Action tremor (HP:0002345) | 1.50345087 |
| 170 | Increased cerebral lipofuscin (HP:0011813) | 1.50301279 |
| 171 | Mitral regurgitation (HP:0001653) | 1.49809534 |
| 172 | Hallux valgus (HP:0001822) | 1.49487063 |
| 173 | Joint laxity (HP:0001388) | 1.46854230 |
| 174 | Pathologic fracture (HP:0002756) | 1.46246326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.57811240 |
| 2 | MAP3K10 | 3.41533353 |
| 3 | PRPF4B | 3.23196071 |
| 4 | EEF2K | 3.18813263 |
| 5 | PKN2 | 2.99384163 |
| 6 | IRAK3 | 2.88750395 |
| 7 | MAP4K1 | 2.49350439 |
| 8 | LATS2 | 2.49289287 |
| 9 | CDK12 | 2.38551597 |
| 10 | MST1R | 2.37647730 |
| 11 | MAP3K14 | 2.10237015 |
| 12 | SMG1 | 2.05733319 |
| 13 | PDGFRA | 1.87572079 |
| 14 | RIPK1 | 1.77429583 |
| 15 | SIK2 | 1.76147239 |
| 16 | PTK6 | 1.76091535 |
| 17 | KSR2 | 1.75841701 |
| 18 | SIK1 | 1.74773963 |
| 19 | TYRO3 | 1.72882100 |
| 20 | MOS | 1.68350388 |
| 21 | ERN1 | 1.66285597 |
| 22 | LRRK2 | 1.64619608 |
| 23 | GRK6 | 1.63670557 |
| 24 | ALK | 1.59826717 |
| 25 | STK10 | 1.57596753 |
| 26 | MET | 1.57391433 |
| 27 | RET | 1.52927520 |
| 28 | TAOK2 | 1.51243265 |
| 29 | MAP3K3 | 1.48165445 |
| 30 | PRKCH | 1.44423196 |
| 31 | MAP3K9 | 1.42852666 |
| 32 | ARAF | 1.41230945 |
| 33 | ITK | 1.39634442 |
| 34 | KSR1 | 1.39119279 |
| 35 | PDGFRB | 1.38935754 |
| 36 | FGFR4 | 1.37860270 |
| 37 | CAMK1G | 1.37262856 |
| 38 | EPHA2 | 1.30036593 |
| 39 | HIPK2 | 1.28799051 |
| 40 | SCYL2 | 1.27991582 |
| 41 | FGR | 1.27616432 |
| 42 | NME2 | 1.25683863 |
| 43 | FGFR2 | 1.23229744 |
| 44 | FGFR3 | 1.19375780 |
| 45 | MAP3K1 | 1.15016703 |
| 46 | MAP2K3 | 1.14257618 |
| 47 | PAK6 | 1.14165727 |
| 48 | JAK1 | 1.13678768 |
| 49 | CAMK1D | 1.09663659 |
| 50 | NTRK3 | 1.07498305 |
| 51 | MAP3K2 | 1.07313753 |
| 52 | DYRK1B | 1.06154485 |
| 53 | NTRK1 | 1.05721177 |
| 54 | ICK | 1.04780210 |
| 55 | ZAP70 | 1.04136532 |
| 56 | JAK3 | 1.03743459 |
| 57 | STK24 | 1.02792938 |
| 58 | TESK1 | 1.02586496 |
| 59 | TAOK1 | 1.00999870 |
| 60 | PTK2 | 1.00429229 |
| 61 | UHMK1 | 0.99316813 |
| 62 | MAP3K7 | 0.96347967 |
| 63 | FGFR1 | 0.94647336 |
| 64 | BRD4 | 0.93373324 |
| 65 | PRKD3 | 0.93239418 |
| 66 | YES1 | 0.91670216 |
| 67 | PASK | 0.91187338 |
| 68 | TGFBR2 | 0.91144230 |
| 69 | TBK1 | 0.90101472 |
| 70 | MTOR | 0.89870244 |
| 71 | HCK | 0.86847904 |
| 72 | MAP3K13 | 0.86833595 |
| 73 | IRAK4 | 0.83021463 |
| 74 | SIK3 | 0.82778215 |
| 75 | ERBB4 | 0.79836011 |
| 76 | BMX | 0.79233059 |
| 77 | PAK3 | 0.78604959 |
| 78 | NEK9 | 0.78034293 |
| 79 | JAK2 | 0.78005580 |
| 80 | CDC42BPA | 0.75818583 |
| 81 | CSK | 0.75810620 |
| 82 | MARK2 | 0.75462618 |
| 83 | TYK2 | 0.73826708 |
| 84 | NEK2 | 0.72866190 |
| 85 | MAP3K6 | 0.72576908 |
| 86 | MARK3 | 0.71891714 |
| 87 | IRAK2 | 0.71466420 |
| 88 | CDK6 | 0.70975224 |
| 89 | EPHA3 | 0.70973710 |
| 90 | MAP3K4 | 0.70199119 |
| 91 | MELK | 0.69926412 |
| 92 | WNK1 | 0.69841287 |
| 93 | GRK7 | 0.67907610 |
| 94 | CLK1 | 0.67052107 |
| 95 | TTN | 0.66357043 |
| 96 | NTRK2 | 0.65786680 |
| 97 | EPHB1 | 0.64961805 |
| 98 | ACVR1B | 0.64411477 |
| 99 | SYK | 0.64295647 |
| 100 | MAP3K11 | 0.63857562 |
| 101 | DAPK2 | 0.63650735 |
| 102 | EPHB2 | 0.62901310 |
| 103 | BLK | 0.62003150 |
| 104 | RPS6KA4 | 0.61922035 |
| 105 | PRKD2 | 0.61267714 |
| 106 | LCK | 0.60437510 |
| 107 | CAMKK1 | 0.60300520 |
| 108 | PAK2 | 0.59315547 |
| 109 | MATK | 0.59273634 |
| 110 | FYN | 0.58559072 |
| 111 | TGFBR1 | 0.57987712 |
| 112 | RIPK4 | 0.56756422 |
| 113 | ROCK2 | 0.55849562 |
| 114 | EPHA4 | 0.55821135 |
| 115 | INSR | 0.52647020 |
| 116 | BTK | 0.51714573 |
| 117 | DDR2 | 0.51553259 |
| 118 | RPS6KA2 | 0.51308823 |
| 119 | STK38 | 0.50999941 |
| 120 | IRAK1 | 0.50124429 |
| 121 | CDK5 | 0.50104994 |
| 122 | ERBB2 | 0.49400407 |
| 123 | TRPM7 | 0.49302921 |
| 124 | STK11 | 0.48077952 |
| 125 | DMPK | 0.47286454 |
| 126 | CSF1R | 0.46983862 |
| 127 | LATS1 | 0.45966835 |
| 128 | CDK4 | 0.45364499 |
| 129 | PDK1 | 0.44757461 |
| 130 | SGK3 | 0.44208703 |
| 131 | SRC | 0.43409949 |
| 132 | MAP3K8 | 0.43045222 |
| 133 | PIM2 | 0.42879537 |
| 134 | EGFR | 0.42252910 |
| 135 | PAK4 | 0.41746207 |
| 136 | WNK3 | 0.40988112 |
| 137 | PRKD1 | 0.40168473 |
| 138 | MARK1 | 0.39356199 |
| 139 | PDPK1 | 0.38767187 |
| 140 | RPS6KC1 | 0.36478357 |
| 141 | RPS6KL1 | 0.36478357 |
| 142 | IKBKE | 0.35409160 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.01840569 |
| 2 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.93984137 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.91468945 |
| 4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.69764433 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.68925640 |
| 6 | Malaria_Homo sapiens_hsa05144 | 1.65649216 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64784722 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.63510937 |
| 9 | Amoebiasis_Homo sapiens_hsa05146 | 1.63490322 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.62120345 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57219071 |
| 12 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.57167972 |
| 13 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.51717717 |
| 14 | Prion diseases_Homo sapiens_hsa05020 | 1.51260389 |
| 15 | Colorectal cancer_Homo sapiens_hsa05210 | 1.50321709 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.46744139 |
| 17 | Salmonella infection_Homo sapiens_hsa05132 | 1.46635183 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44664069 |
| 19 | Long-term potentiation_Homo sapiens_hsa04720 | 1.38512350 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38148877 |
| 21 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.36182727 |
| 22 | Glioma_Homo sapiens_hsa05214 | 1.36155623 |
| 23 | Endometrial cancer_Homo sapiens_hsa05213 | 1.35874758 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.35211832 |
| 25 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.34997850 |
| 26 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33994950 |
| 27 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.32257339 |
| 28 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31343519 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28294475 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26504976 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.25862649 |
| 32 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.25637012 |
| 33 | Pertussis_Homo sapiens_hsa05133 | 1.22941385 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.20409161 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.19363778 |
| 36 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17572651 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.16410028 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.15994567 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.15026966 |
| 40 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14379974 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.12248759 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12096064 |
| 43 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11260013 |
| 44 | Insulin secretion_Homo sapiens_hsa04911 | 1.10731955 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10037456 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09932559 |
| 47 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.09338158 |
| 48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.08172292 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.06702427 |
| 50 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.06078023 |
| 51 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05972658 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.05485083 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.05437504 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.03729975 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 1.03341308 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.03088621 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 1.02659695 |
| 58 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00756380 |
| 59 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00260381 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 0.99888475 |
| 61 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99861020 |
| 62 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.98060265 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97828895 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.97334021 |
| 65 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97156409 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97147148 |
| 67 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96855586 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.95255766 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94682722 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94569030 |
| 71 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94092373 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.93521230 |
| 73 | Salivary secretion_Homo sapiens_hsa04970 | 0.92731482 |
| 74 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.92680494 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.91506012 |
| 76 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90544294 |
| 77 | Viral myocarditis_Homo sapiens_hsa05416 | 0.89839679 |
| 78 | Renin secretion_Homo sapiens_hsa04924 | 0.89611470 |
| 79 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.89504653 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.89174740 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.89029476 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.88953304 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87964665 |
| 84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.87736103 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87162275 |
| 86 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87094406 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.86428655 |
| 88 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86208022 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.86175608 |
| 90 | Cocaine addiction_Homo sapiens_hsa05030 | 0.86150874 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.86114302 |
| 92 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.85856170 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.85822179 |
| 94 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85482892 |
| 95 | Axon guidance_Homo sapiens_hsa04360 | 0.85084488 |
| 96 | Bladder cancer_Homo sapiens_hsa05219 | 0.83565546 |
| 97 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.83092201 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.82798938 |
| 99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.82683012 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.82674980 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82163615 |
| 102 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82088646 |
| 103 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81818117 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.80922504 |
| 105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.80676504 |
| 106 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80410815 |
| 107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.80387284 |
| 108 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.80178526 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.79461414 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79097105 |
| 111 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78986383 |
| 112 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78789855 |
| 113 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.78486855 |
| 114 | Thyroid cancer_Homo sapiens_hsa05216 | 0.78114466 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78014750 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.77795792 |
| 117 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.77641050 |
| 118 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77581700 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.77405408 |
| 120 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77053503 |
| 121 | Allograft rejection_Homo sapiens_hsa05330 | 0.76606456 |
| 122 | Morphine addiction_Homo sapiens_hsa05032 | 0.75926135 |
| 123 | GABAergic synapse_Homo sapiens_hsa04727 | 0.75280062 |
| 124 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74929271 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.73268637 |
| 126 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71495796 |
| 127 | Melanogenesis_Homo sapiens_hsa04916 | 0.69743212 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.69499885 |
| 129 | Shigellosis_Homo sapiens_hsa05131 | 0.69185475 |
| 130 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69149123 |
| 131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69003258 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68882957 |
| 133 | Prostate cancer_Homo sapiens_hsa05215 | 0.68357918 |
| 134 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.68300495 |
| 135 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.67584057 |
| 136 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67493795 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67008719 |
| 138 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66281532 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.63923825 |
| 140 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59211900 |
| 141 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58184344 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56008401 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55775646 |
| 144 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53231588 |

